Location History:
- Ecully, FR (2005 - 2007)
- Celletes, FR (2010)
- Chambon sur Cisse, FR (2010 - 2018)
Company Filing History:
6 out of 5,089 
1 out of 1 
1 out of 280 
Years Active: 2005-2018
Title: Eliane Souteyrand: A Trailblazer in Pharmaceutical Innovations
Introduction
Eliane Souteyrand, hailing from Chambon sur Cisse, France, is a distinguished inventor renowned for her significant contributions to the field of pharmaceuticals. With a portfolio of 7 patents, her innovative work has focused on developing compounds with therapeutic potential, particularly in combating bacterial infections.
Latest Patents
Souteyrand's latest patents showcase her pioneering spirit and scientific expertise. One notable invention is regarding glycoclusters and their pharmaceutical use as antibacterials. This invention outlines a molecule that adheres to a specific formula, with galactose residues at the extremities. The methods described are simple yet efficient, providing a pathway for synthesizing these compounds and utilizing them as inhibitors against various infections by targeting bacterial virulence.
Another significant patent is her method for synthesizing oligonucleotide derivatives. This invention employs 'click chemistry' to graft molecules of interest onto the oligonucleotide. By utilizing an azide function and alkyne function, she paves the way for creating intermediate products, including alkyne-functionalized oligonucleotides and grafted oligonucleotides. The implications of this work extend to biological investigations and targeted cell therapies.
Career Highlights
Eliane Souteyrand has made her mark in the scientific community through her work with prestigious organizations. She has been associated with the Centre National de la Recherche Scientifique, where she contributed to various research initiatives. Additionally, her tenure at Biotray Sas has further honed her expertise in innovative pharmaceutical research and development.
Collaborations
Throughout her career, Souteyrand has been fortunate to collaborate with esteemed colleagues, including Jean-Pierre Cloarec and Jean-Jacques Vasseur. These collaborations have fostered the exchange of ideas and have played a pivotal role in advancing her innovative research.
Conclusion
Eliane Souteyrand stands as a remarkable figure in the landscape of pharmaceutical innovation. Her groundbreaking patents reflect her commitment to enhancing medical science and improving healthcare outcomes. As she continues to push the boundaries of research and invention, her contributions will undoubtedly pave the way for future advancements in the field.